[Microbial sensitivity spectrum of framycetin. Comparison with the 1972 to 1993 resistance status].
Framycetin was tested against a variety of isolates of grampositive and gramnegative bacteria. The in-vitro activity of Framycetin against Staphylococcus aureus, Enterobacteriaceae, Pseudomonas aeruginosa as well as Pseudomonas fluorescens is today still favourable.
Knothe
H
H
Zentrum der Hygiene, Universitätsklinik Frankfurt.
Hauke
W
W
D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy* / Q000382:microbiology; D004305:Dose-Response Relationship, Drug; D016983:Enterococcus / Q000187:drug effects; D005601:Framycetin / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects
D005601:Framycetin